Update on the patentability of antibodies at the European Patent Office
European
News
14/03/2024
In a series of articles relating to the patentability of antibodies, we have previously provided an outline of the requirements associated with patenting antibodies and related biologics at the European Patent Office (EPO). In particular, we focused on the different ways an antibody can be claimed at the EPO and also the information often required in a patent application to support the presence of an inventive step.
Read more